What treatments are approved for myeloma in Ontario, Canada?
Treatment approvals in Ontario (and across Canada) are handled through Health Canada and provincial funding bodies like the Ontario Drug Benefit (ODB) program and Cancer Care Ontario. These can differ from U.S. FDA approvals, so it's worth knowing what's Show Full Answer
What treatments are approved for myeloma in Ontario, Canada?
Treatment approvals in Ontario (and across Canada) are handled through Health Canada and provincial funding bodies like the Ontario Drug Benefit (ODB) program and Cancer Care Ontario. These can differ from U.S. FDA approvals, so it's worth knowing what's available.
Generally, myeloma treatments fall into these categories:
- Chemotherapy & targeted therapies – including proteasome inhibitors (e.g., bortezomib, carfilzomib) and immunomodulatory drugs (e.g., lenalidomide, pomalidomide)
- Anti-CD38 therapies – such as daratumumab (Darzalex)
- CAR T-cell therapy – newer options like Abecma and Carvykti are available in some Canadian centres
- Stem cell transplants – autologous transplant remains a standard treatment
- Clinical trials – promising new therapies may be accessible this way
For the most accurate and up-to-date information on what's funded and approved in Ontario specifically, speaking directly with your hematologist-oncologist is the best step. They can also help navigate provincial funding applications if a treatment isn't automatically covered.
June 5
Join
Your Privacy Choices
